{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:39:12Z","timestamp":1784921952962,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["102604"],"award-info":[{"award-number":["102604"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1162929"],"award-info":[{"award-number":["1162929"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154992"],"award-info":[{"award-number":["1154992"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic testing is used to optimise the management of inherited cardiovascular disorders that can cause sudden cardiac death. Yet more genotype\u2013phenotype correlation studies from populations not ascertained on clinical symptoms or family history of disease are required to improve understanding of gene penetrance. We performed targeted sequencing of 25 genes used routinely in clinical genetic testing for inherited cardiovascular disorders in a population of 13,131 asymptomatic older individuals (mean age 75 years) enrolled in the ASPREE trial. Participants had no prior history of cardiovascular disease events, dementia or physical disability at enrolment. Variants were classified following ACMG\/AMP standards. Sudden and rapid cardiac deaths were clinically adjudicated as ASPREE trial endpoints, and assessed during mean 4.7 years of follow-up. In total, 119 participants had pathogenic\/deleterious variants in one of the 25 genes analysed (carrier rate of 1 in 110 or 0.9%). Participants carried variants associated with hypertrophic cardiomyopathy (<jats:italic>N<\/jats:italic>\u2009=\u200924), dilated cardiomyopathy (N\u2009=\u200929), arrhythmogenic right-ventricular cardiomyopathy (<jats:italic>N<\/jats:italic>\u2009=\u200922), catecholaminergic polymorphic ventricular tachycardia (<jats:italic>N<\/jats:italic>\u2009=\u20094), aortopathies (<jats:italic>N<\/jats:italic>\u2009=\u20091), and long-QT syndrome (<jats:italic>N<\/jats:italic>\u2009=\u200939). Among 119 carriers, two died from presumed sudden\/rapid cardiac deaths during follow-up (1.7%); both with pathogenic variants in long-QT syndrome genes (<jats:italic>KCNQ1<\/jats:italic>, <jats:italic>SCN5A<\/jats:italic>). Among non-carriers, the rate of sudden\/rapid cardiac deaths was significantly lower (0.08%, 11\/12936, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Variants associated with inherited cardiovascular disorders are found in asymptomatic individuals aged 70 years and older without a history of cardiovascular disease.<\/jats:p>","DOI":"10.1038\/s41525-021-00211-x","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:03:04Z","timestamp":1623837784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0902-6798","authenticated-orcid":false,"given":"Paul","family":"Lacaze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sebra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeen","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Ingles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-6632","authenticated-orcid":false,"given":"Jane","family":"Tiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryony A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Fatkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Semsarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Tonkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Winship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Schadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-5129","authenticated-orcid":false,"given":"John J.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"211_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.hlc.2019.10.014","volume":"29","author":"J Ingles","year":"2020","unstructured":"Ingles, J., Macciocca, I., Morales, A. & Thomson, K. Genetic testing in inherited heart diseases. Heart Lung Circ. 29, 505\u2013511 (2020).","journal-title":"Heart Lung Circ."},{"key":"211_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/jamacardio.2017.2352","volume":"2","author":"AL Cirino","year":"2017","unstructured":"Cirino, A. L. et al. Role of genetic testing in inherited cardiovascular disease: a review. JAMA Cardiol. 2, 1153\u20131160 (2017).","journal-title":"JAMA Cardiol."},{"key":"211_CR3","doi-asserted-by":"publisher","unstructured":"Coll, M. et al. Incomplete penetrance and variable expressivity: hallmarks in channelopathies associated with sudden cardiac death. Biology (Basel) https:\/\/doi.org\/10.3390\/biology7010003 (2017).","DOI":"10.3390\/biology7010003"},{"key":"211_CR4","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","volume":"12","author":"J Ingles","year":"2019","unstructured":"Ingles, J. et al. Evaluating the clinical validity of hypertrophic cardiomyopathy genes. Circ. Genom. Precis. Med. 12, e002460 (2019).","journal-title":"Circ. Genom. Precis. Med."},{"key":"211_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.119.043132","volume":"141","author":"A Adler","year":"2020","unstructured":"Adler, A. et al. An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome. Circulation 141, 418\u2013428 (2020).","journal-title":"Circulation"},{"key":"211_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.118.035070","volume":"138","author":"SM Hosseini","year":"2018","unstructured":"Hosseini, S. M. et al. Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for brugada syndrome. Circulation 138, 1195\u20131205 (2018).","journal-title":"Circulation"},{"key":"211_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","volume":"138","author":"CY Ho","year":"2018","unstructured":"Ho, C. Y. et al. Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe). Circulation 138, 1387\u20131398 (2018).","journal-title":"Circulation"},{"key":"211_CR8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.hrthm.2009.05.021","volume":"6","author":"JD Kapplinger","year":"2009","unstructured":"Kapplinger, J. D. et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 6, 1297\u20131303 (2009).","journal-title":"Heart Rhythm"},{"key":"211_CR9","doi-asserted-by":"publisher","first-page":"e002579","DOI":"10.1161\/CIRCGEN.119.002579","volume":"12","author":"ED Carruth","year":"2019","unstructured":"Carruth, E. D. et al. Prevalence and electronic health record-based phenotype of loss-of-function genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes. Circ. Genom. Precis. Med. 12, e002579 (2019).","journal-title":"Circ. Genom. Precis. Med."},{"key":"211_CR10","doi-asserted-by":"publisher","first-page":"102732","DOI":"10.1016\/j.ebiom.2020.102732","volume":"54","author":"O Campuzano","year":"2020","unstructured":"Campuzano, O. et al. Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes. EBioMedicine 54, 102732 (2020).","journal-title":"EBioMedicine"},{"key":"211_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.2015.17701","volume":"315","author":"SL Van Driest","year":"2016","unstructured":"Van Driest, S. L. et al. Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records. JAMA 315, 47\u201357 (2016).","journal-title":"JAMA"},{"key":"211_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41436-019-0625-8","volume":"22","author":"J Park","year":"2020","unstructured":"Park, J. et al. A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes. Genet. Med. 22, 102\u2013111 (2020).","journal-title":"Genet. Med."},{"key":"211_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.039573","volume":"140","author":"CM Haggerty","year":"2019","unstructured":"Haggerty, C. M. et al. Genomics-first evaluation of heart disease associated with titin-truncating variants. Circulation 140, 42\u201354 (2019).","journal-title":"Circulation"},{"key":"211_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ajhg.2012.07.017","volume":"91","author":"AG Bick","year":"2012","unstructured":"Bick, A. G. et al. Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. Am. J. Hum. Genet. 91, 513\u2013519 (2012).","journal-title":"Am. J. Hum. Genet"},{"key":"211_CR15","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","volume":"374","author":"RD Bagnall","year":"2016","unstructured":"Bagnall, R. D. et al. A prospective study of sudden cardiac death among children and young adults. N. Engl. J. Med. 374, 2441\u20132452 (2016).","journal-title":"N. Engl. J. Med."},{"key":"211_CR16","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil, J. J. et al. Effect of aspirin on disability-free survival in the healthy elderly. N. Engl. J. Med. 379, 1499\u20131508 (2018).","journal-title":"N. Engl. J. Med"},{"key":"211_CR17","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil, J. J. et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N. Engl. J. Med. 379, 1509\u20131518 (2018).","journal-title":"N. Engl. J. Med."},{"key":"211_CR18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil, J. J. et al. Effect of aspirin on all-cause mortality in the healthy elderly. N. Engl. J. Med. 379, 1519\u20131528 (2018).","journal-title":"N. Engl. J. Med."},{"key":"211_CR19","doi-asserted-by":"publisher","unstructured":"Lacaze, P. et al. Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals. Genet. Med. https:\/\/doi.org\/10.1038\/s41436-020-0881-7 (2020).","DOI":"10.1038\/s41436-020-0881-7"},{"key":"211_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2261-14-22","volume":"14","author":"A Winbo","year":"2014","unstructured":"Winbo, A. et al. Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X\/KCNQ1 families. BMC Cardiovasc. Disord. 14, 22 (2014).","journal-title":"BMC Cardiovasc. Disord."},{"key":"211_CR21","first-page":"55","volume":"6","author":"A Svensson","year":"2016","unstructured":"Svensson, A. et al. Arrhythmogenic right ventricular cardiomyopathy-4 Swedish families with an associated PKP2 c.2146-1G\u2009>\u2009C variant. Am. J. Cardiovasc. Dis. 6, 55\u201365 (2016).","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"211_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/medethics-2016-103967","volume":"43","author":"P Lacaze","year":"2017","unstructured":"Lacaze, P., Ryan, J., Woods, R., Winship, I. & McNeil, J. Pathogenic variants in the healthy elderly: unique ethical and practical challenges. J. Med. Ethics 43, 714\u2013722 (2017).","journal-title":"J. Med. Ethics"},{"key":"211_CR23","doi-asserted-by":"publisher","unstructured":"Lahrouchi, N. et al. Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045956 (2020).","DOI":"10.1161\/CIRCULATIONAHA.120.045956"},{"key":"211_CR24","doi-asserted-by":"publisher","unstructured":"Wang, W. et al. Impact of exercise restriction on arrhythmic risk among patients with arrhythmogenic right ventricular cardiomyopathy. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.118.008843 (2018).","DOI":"10.1161\/JAHA.118.008843"},{"key":"211_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cct.2013.09.014","volume":"36","author":"AI Group","year":"2013","unstructured":"Group, A. I. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemp. Clin. Trials 36, 555\u2013564 (2013).","journal-title":"Contemp. Clin. Trials"},{"key":"211_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5694\/mja2.12060","volume":"210","author":"JE Lockery","year":"2019","unstructured":"Lockery, J. E. et al. Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly (ASPREE) study. Med. J. Aust. 210, 168\u2013173 (2019).","journal-title":"Med. J. Aust."},{"key":"211_CR27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/gerona\/glw342","volume":"72","author":"JJ McNeil","year":"2017","unstructured":"McNeil, J. J. et al. Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study. J. Gerontol. A Biol. Sci. Med. Sci. 72, 1586\u20131593 (2017).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"211_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ajhg.2017.04.015","volume":"100","author":"NT Strande","year":"2017","unstructured":"Strande, N. T. et al. Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource. Am. J. Hum. Genet. 100, 895\u2013906 (2017).","journal-title":"Am. J. Hum. Genet"},{"key":"211_CR29","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980\u2013D985 (2014).","journal-title":"Nucleic Acids Res."},{"key":"211_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"211_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"211_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/gim.2017.218","volume":"20","author":"MA Kelly","year":"2018","unstructured":"Kelly, M. A. et al. Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s Inherited Cardiomyopathy Expert Panel. Genet. Med. 20, 351\u2013359 (2018).","journal-title":"Genet. Med."},{"key":"211_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.hlc.2018.09.010","volume":"28","author":"S Peters","year":"2019","unstructured":"Peters, S., Kumar, S., Elliott, P., Kalman, J. M. & Fatkin, D. Arrhythmic genotypes in familial dilated cardiomyopathy: implications for genetic testing and clinical management. Heart Lung Circ. 28, 31\u201338 (2019).","journal-title":"Heart Lung Circ."},{"key":"211_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.hlc.2019.11.018","volume":"29","author":"S Peters","year":"2020","unstructured":"Peters, S. et al. Familial dilated cardiomyopathy. Heart Lung Circ. 29, 566\u2013574 (2020).","journal-title":"Heart Lung Circ."},{"key":"211_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12551-017-0265-7","volume":"9","author":"AM Tabish","year":"2017","unstructured":"Tabish, A. M., Azzimato, V., Alexiadis, A., Buyandelger, B. & Knoll, R. Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy. Biophys. Rev. 9, 207\u2013223 (2017).","journal-title":"Biophys. Rev."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00211-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T20:51:16Z","timestamp":1670014276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00211-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1038\/s41525-021-00211-x","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.S. serves as Vice-President of Technology Development and Sema4. E.S. serves as Chief Executive Officer at Sema4. J.I. receives research grant support from Myokardia, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}